Chemoinformaics analysis of BUTYL TRIDECYL SULFITE
| Molecular Weight | 320.539 | nRot | 17 |
| Heavy Atom Molecular Weight | 284.251 | nRig | 1 |
| Exact Molecular Weight | 320.239 | nRing | 0 |
| Solubility: LogS | -0.651 | nHRing | 0 |
| Solubility: LogP | 1.367 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 57 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 21 | No. of Aromatic Carbocycles | 0 |
| nHetero | 4 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 36 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 17 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 3 | No. of Arom Bond | 0 |
| nHA | 3 | APOL | 57.7005 |
| nHD | 0 | BPOL | 44.1455 |
| QED | 0.53 |
| Synth | 3.218 |
| Natural Product Likeliness | 2.341 |
| NR-PPAR-gamma | 0.007 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0 |
| Pgp-sub | 0.019 |
| HIA | 0.014 |
| CACO-2 | -4.204 |
| MDCK | 0.0000314 |
| BBB | 0.986 |
| PPB | 0.445206 |
| VDSS | 1.061 |
| FU | 0.590001 |
| CYP1A2-inh | 0.263 |
| CYP1A2-sub | 0.862 |
| CYP2c19-inh | 0.05 |
| CYP2c19-sub | 0.867 |
| CYP2c9-inh | 0.014 |
| CYP2c9-sub | 0.852 |
| CYP2d6-inh | 0.009 |
| CYP2d6-sub | 0.728 |
| CYP3a4-inh | 0.014 |
| CYP3a4-sub | 0.29 |
| CL | 8.114 |
| T12 | 0.777 |
| hERG | 0.01 |
| Ames | 0.023 |
| ROA | 0.703 |
| SkinSen | 0.393 |
| Carcinogencity | 0.052 |
| EI | 0.984 |
| Respiratory | 0.189 |
| NR-Aromatase | 0.004 |
| Antiviral | Yes |
| Prediction | 0.661683 |